13
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Incidence and Clinical Characteristics of COVID-19 Ophthalmopathy Following the Termination of Dynamic Zero COVID-19 Strategy in China

&
Received 01 Aug 2023, Accepted 26 Feb 2024, Published online: 12 Mar 2024

References

  • Öncül H, Öncül FY, Alakus MF, et al. Ocular findings in patients with coronavirus disease 2019 (COVID-19) in an outbreak hospital. J Med Virol. 2021;93(2):1126–1132. doi:10.1002/jmv.26412.
  • Shaikh N, Al Mahdi H, Pai A, et al. Ocular manifestations of COVID-19: facts and figures from a tertiary care center. Ann Med. 2022;54(1):310–313. doi:10.1080/07853890.2022.2029554.
  • Tisdale AK, Dinkin M, Chwalisz BK. Afferent and efferent neuro-ophthalmic complications of coronavirus disease 19. J Neuroophthalmol. 2021;41(2):154–165. doi:10.1097/WNO.0000000000001276.
  • Alnahdi MA, Alkharashi M. Ocular manifestations of COVID-19 in the pediatric age group. Eur J Ophthalmol. 2023;33(1):21–28. doi:10.1177/11206721221116210.
  • Zhou Y, Duan C, Zeng Y, et al. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology. 2020;127(7):982–983. doi:10.1016/j.ophtha.2020.04.028.
  • Aubart M, Roux CJ, Durrleman C, et al. Neuroinflammatory disease following severe acute respiratory syndrome coronavirus 2 infection in children. J Pediatr. 2022;247:22–28. e2. doi:10.1016/j.jpeds.2022.05.018.
  • Zhou Y, Zhi H, Teng Y. The outbreak of SARS-CoV-2 Omicron lineages, immune escape, and vaccine effectivity. J Med Virol. 2023;95(1):e28138. doi:10.1002/jmv.28138.
  • Lu G, Ling Y, Jiang MH, et al. Primary assessment of the diversity of omicron sublineages and the epidemiologic features of autumn/winter 2022 COVID-19 wave in Chinese mainland. Front Med. 2023;17(4):758–767. doi:10.1007/s11684-022-0981-7.
  • The National Health Commission of the People’s Republic of China. Text transcript of the press conference about SARS-CoV-2 control and prevention of the state council on January 14, 2023: summary of SARS-CoV-2 infected cases from 8 December 2022 to 12 January 2023. 2023. http://www.nhc.gov.cn/xcs/yqfkdt/202301/a68301ee500b436b989ec5be2a35cad2.shtml.
  • Chinese Center for Disease Control and Prevention. Summary of SARS-CoV-2 infected cases from 12 January 2023 to 19 January 2023. 2023. https://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_13141/202301/t20230121_263515.html.
  • Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol. 2020;138(5):575–578. doi:10.1001/jamaophthalmol.2020.1291.
  • Chinese Center for Disease Control and Prevention. Summary of SARS-CoV-2 infected cases from 9 December 2022 to 27 April 2023. 2023. https://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_13141/202304/t20230429_265709.html.
  • Romero-Castro RM, Ruiz-Cruz M, Alvarado-de la Barrera C, et al. Posterior segment ocular findings in critically ill patients with COVID-19. Retina. 2022;42(4):628–633. doi:10.1097/IAE.0000000000003457.
  • Kene RD, Shafeena PP, Kumar MK, et al. Neuro-ophthalmic Sequelae in COVID-19 Recovered Cases. Indian, J Ophthalmol. 2022;70(10):3736–3737. doi:10.4103/ijo.IJO_1495_22.
  • Roshanshad A, Ashraf MA, Roshanshad R, et al. Ocular manifestations of patients with coronavirus disease 2019: a comprehensive review. J Ophthalmic Vis Res. 2021;16(2):234–247. doi:10.18502/jovr.v16i2.9087.
  • Casagrande M, Fitzek A, Spitzer M, et al. Detection of SARS-CoV-2 genomic and subgenomic RNA in retina and optic nerve of patients with COVID-19. Br J Ophthalmol. 2022;106(9):1313–1317. doi:10.1136/bjophthalmol-2020-318618.
  • Penkava J, Muenchhoff M, Badell I, et al. Detection of SARS-CoV-2-RNA in post-mortem samples of human eyes. Graefes Arch Clin Exp Ophthalmol. 2022;260(5):1789–1797. doi:10.1007/s00417-021-05529-x.
  • Ferrari S, Franco E, Del Vecchio C, et al. Presence of SARS-CoV-2 RNA in human corneal tissues donated in Italy during the COVID-19 pandemic. BMJ Open Ophthalmol. 2022;7(1):e000990. doi:10.1136/bmjophth-2022-000990.
  • Végh A, Csorba A, Koller Á, et al. Presence of SARS-CoV-2 on the conjunctival mucosa in patients hospitalized due to COVID-19: pathophysiological considerations and therapeutic implications. Physiol Int. 2022;109(4):475–485. doi:10.1556/2060.2022.00113.
  • Duran M, Aykaç S. Optic neuritis after COVID-19 infection: a case report. J Fr Ophtalmol. 2023;46(1):e4–e7. doi:10.1016/j.jfo.2022.09.005.
  • Kivanany PB, Raviskanthan S, Mortensen PW, et al. Antiaquaporin 4-related optic neuritis and myelitis post-COVID-19 infection. J Neuroophthalmol. 2022;42(4):e571–e573. doi:10.1097/WNO.0000000000001347.
  • Assavapongpaiboon B, Apinyawasisuk S, Jariyakosol S. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis with COVID-19 infection: a case report and literature review. Am J Ophthalmol Case Rep. 2022;26:101491. doi:10.1016/j.ajoc.2022.101491.
  • Sawalha K, Adeodokun S, Kamoga GR. COVID-19-induced acute bilateral optic neuritis. J Investig Med High Impact Case Rep. 2020;8:2324709620976018. doi:10.1177/2324709620976018.
  • Ide T, Kawanami T, Eriguchi M, et al. SARS-CoV-2-related myelin oligodendrocyte glycoprotein antibody-associated disease: a case report and literature review. Intern Med. 2022;61(8):1253–1258. doi:10.2169/internalmedicine.8709-21.
  • Sanoria A, Jain P, Arora R, et al. Bilateral sequential non-arteritic optic neuropathy post-COVID-19. Indian, J Ophthalmol. 2022;70(2):676–679. doi:10.4103/ijo.IJO_2365_21.
  • Babazadeh A, Barary M, Ebrahimpour S, et al. Non-arteritic anterior ischemic optic neuropathy as an atypical feature of COVID-19: a case report. J Fr Ophtalmol. 2022;45(4):e171–e173. doi:10.1016/j.jfo.2021.12.001.
  • Giacuzzo C, Eandi CM, Kawasaki A. Bilateral acute macular neuroretinopathy following COVID-19 infection. Acta Ophthalmol. 2022;100(2):e611–e612. doi:10.1111/aos.14913.
  • Shroff D, Kumar S, Naidu A, et al. Retinal vasoocclusive spectrum following COVID-19. Indian, J Ophthalmol. 2022;70(4):1412–1415. doi:10.4103/ijo.IJO_2837_21.
  • Dinkin M, Feinberg E, Oliveira C, et al. Orbital inflammation with optic perineuritis in association with COVID-19. J Neuroophthalmol. 2022;42(1):e300–e301. doi:10.1097/WNO.0000000000001229.
  • Sim AYC, Naffi AA, Fai TS, et al. Bilateral intermediate uveitis in a healthy teenager with the multisystem inflammatory syndrome in children secondary to COVID-19 infection. J Med Virol. 2022;94(4):1269–1271. doi:10.1002/jmv.27521.
  • Sun CB. Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection. Front Immunol. 2023;14:1296518. doi:10.3389/fimmu.2023.1296518.
  • Deane K, Sarfraz A, Sarfraz Z, et al. Unilateral optic neuritis associated with SARS-CoV-2 infection: a rare complication. Am J Case Rep. 2021;22:e931665. doi:10.12659/AJCR.931665.
  • Benito-Pascual B, Gegúndez JA, Díaz-Valle D, et al. Panuveitis and optic neuritis as a possible initial presentation of the novel coronavirus disease 2019 (COVID-19). Ocul Immunol Inflamm. 2020;28(6):922–925. doi:10.1080/09273948.2020.1792512.
  • Swets MC, Russell CD, Harrison EM, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet. 2022;399(10334):1463–1464. doi:10.1016/S0140-6736(22)00383-X.
  • Jain M, Brar AS, Rath S, et al. Fulminant fungal endogenous endophthalmitis following SARS-CoV-2 infection: a case report. Indian, J Ophthalmol. 2022;70(5):1819–1821. doi:10.4103/ijo.IJO_1951_21.
  • Petzold A, Fraser CL, Abegg M, et al. Diagnosis and classification of optic neuritis. Lancet Neurol. 2022;21(12):1120–1134. doi:10.1016/S1474-4422(22)00200-9.
  • Bennett JL, Costello F, Chen JJ, et al. Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment. Lancet Neurol. 2023;22(1):89–100. doi:10.1016/S1474-4422(22)00187-9.
  • Sun CB, Xiao Q, Bai HX, et al. Etiology and ophthalmic characteristics of infectious and infection-related optic neuropathies. Yan Ke Xue Bao. 2020;35(5):327–336. doi:10.3978/j.issn.1000-4432.2020.11.15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.